GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Epi Biotech Co Ltd (XKRX:446440) » Definitions » Net Income (Continuing Operations)

Epi Biotech Co (XKRX:446440) Net Income (Continuing Operations) : ₩0.00 Mil (TTM As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Epi Biotech Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Epi Biotech Co's Net Income (Continuing Operations) for the six months ended in . 20 was ₩0.00 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in . 20 was ₩0.00 Mil.

Epi Biotech Co Net Income (Continuing Operations) Historical Data

The historical data trend for Epi Biotech Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epi Biotech Co Net Income (Continuing Operations) Chart

Epi Biotech Co Annual Data
Trend
Net Income (Continuing Operations)

Epi Biotech Co Semi-Annual Data
Net Income (Continuing Operations)

Epi Biotech Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in . 20 was ₩0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epi Biotech Co  (XKRX:446440) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Epi Biotech Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Epi Biotech Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Epi Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Epi Biotech Co Ltd (XKRX:446440) » Definitions » Net Income (Continuing Operations)
Comparable Companies
XKRX:327610 XKRX:065650 XKRX:298060 XKRX:179530 XKRX:343090 XKRX:344860 XKRX:199730 XKRX:322970 XKRX:215380 XKRX:188260 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
32, Songdogwahak-ro, Rooms 1903 and 1904, 15th floor, M-dong, Yeonsu-gu, Incheon, KOR, 21984
Website
http://www.epibiotech.com
Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin regeneration treatments to create commercially viable consumer products. The company specializes in hair loss treatment in Korea.

Epi Biotech Co Headlines

No Headlines